XML 97 R78.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Long-Term Investments (Details) - Schedule of Balance Sheet - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
BioFirst [Member]      
Condensed Balance Sheet Statements, Captions [Line Items]      
Current Assets $ 1,439,444 $ 1,451,877 $ 1,543,151
Non-current Assets 651,560 686,206 739,472
Current Liabilities 2,663,111 2,286,058 2,663,051
Non-current Liabilities 101,908 347,193 103,447
Stockholders’ Equity (674,015) (495,168) (483,874)
Rgene [Member]      
Condensed Balance Sheet Statements, Captions [Line Items]      
Current Assets 49,496 50,538 68,302
Non-current Assets 238,193 250,716 303,893
Current Liabilities 2,535,581 2,591,960 2,478,868
Non-current Liabilities 1,194 811 2,441
Stockholders’ Equity $ (2,249,086) $ (2,291,517) $ (2,481,309)